EXECUTIVE ENGAGEMENTS
OUTREACH
13024
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1563
Interactions with Platform & by Email
PARTICIPANTS
391
Unique # Participated
VALIDATIONS
176
Responses Validated*
* Login for a full stack data experience
DATE
SEP 2020
TABLES
213
PAGES
307
EDITION
15
PRICE
USD $5600
Focus On Spray, One of the Largest Segments in the Intranasal Drug Delivery Market.
Will this Market be a Huge Opportunity by 2025?
Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Spray, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$19.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drop segment is readjusted to a revised 5% CAGR for the next 7-year period.
The Intranasal Drug Delivery market in the U.S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$10 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.8 Billion by the year 2027, while Latin America will expand at a 4.5% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 307-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
SELECT PLAYERS
Aegis Therapeutics LLC; AptarGroup, Inc.; AstraZeneca Plc; Becton Dickinson and Company; GlaxoSmithKline Plc; Johnson & Johnson; Marina Biotech, Inc.; MedImmune, Inc.; Merck & Co., Inc.; Nemera; Novartis AG; OptiNose US Inc.; Pfizer Inc.; Valeant Pharmaceuticals International, Inc.
SEGMENTS
» Dosage Form (Spray, Drop, Gel, Powder) » Application (Nasal Congestion, Rhinitis, Asthma, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of Covid-19 and a Looming Global Recession |
| A Prelude |
| Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier |
| Recent Market Activity |
| Factors Inhibiting Nose-to-Brain Transportation of Drugs |
| Bioavailability: An Important Facet of Intranasal Drug Delivery |
| Outlook |
| Nasal Drug Delivery Devices & Equipment |
| Traditional Vs. Advanced Intranasal Drug Formulation Types |
| Global Competitor Market Shares |
| Intranasal Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies |
| Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era |
| Pharmaceutical and Medical Device Companies Vying to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients |
| The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis |
| The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment |
| The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis |
| The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment |
| Intranasal Corticosteroids - A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease |
| Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight |
| Innovation in Drug Delivery: A Talisman for Success |
| Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications |
| Controlled Release Technology Is the Buzz Word |
| Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery |
| Tight Junction Biology: A Key Speed Breaker in Commercialization |
| RNA Interference (RNAi): A Tool to Manipulate Tight Junctions |
| Research Studies Authenticate Benefits of Bi-Directional Nasal Drug Delivery |
| Growing Interest for Preservative-free Nasal Spray Formulations |
| Multi-Dose Containers Developed to Offer Resistance against Microbial Contamination |
| 4. GLOBAL MARKET PERSPECTIVE |
| Intranasal Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Intranasal Drug Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Intranasal Drug Delivery Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Spray (Dosage Form) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Spray (Dosage Form) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Spray (Dosage Form) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Drop (Dosage Form) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Drop (Dosage Form) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Drop (Dosage Form) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Gel (Dosage Form) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Gel (Dosage Form) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 |
| Gel (Dosage Form) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Powder (Dosage Form) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Powder (Dosage Form) Market Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Powder (Dosage Form) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Nasal Congestion (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Nasal Congestion (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Nasal Congestion (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Rhinitis (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Rhinitis (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 |
| Rhinitis (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| Asthma (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| Asthma (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Asthma (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027 |
| Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019 |
| Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Intranasal Drug Delivery Market Share (in %) by Company: 2018 & 2025 |
| United States Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027 |
| Intranasal Drug Delivery Market in the United States by Dosage Form: A Historic Review in US$ Million for 2012-2019 |
| United States Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| United States Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 |
| Intranasal Drug Delivery Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 |
| Canada |
| Canadian Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027 |
| Canadian Intranasal Drug Delivery Historic Market Review by Dosage Form in US$ Million: 2012-2019 |
| Intranasal Drug Delivery Market in Canada: Percentage Share Breakdown of Sales by Dosage Form for 2012, 2020, and 2027 |
| Canadian Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Canadian Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Japan |
| Japanese Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Market in Japan: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019 |
| Japanese Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Japanese Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 |
| China |
| Chinese Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Historic Market Analysis in China in US$ Million by Dosage Form: 2012-2019 |
| Chinese Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market Review in China in US$ Million by Application: 2012-2019 |
| Chinese Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Europe |
| Market Facts & Figures |
| European Intranasal Drug Delivery Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Intranasal Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Intranasal Drug Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Intranasal Drug Delivery Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027 |
| Intranasal Drug Delivery Market in Europe in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019 |
| European Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| European Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Intranasal Drug Delivery Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| European Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| France |
| Intranasal Drug Delivery Market in France by Dosage Form: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Intranasal Drug Delivery Historic Market Scenario in US$ Million by Dosage Form: 2012-2019 |
| French Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 |
| French Intranasal Drug Delivery Historic Market Review in US$ Million by Application: 2012-2019 |
| French Intranasal Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Germany |
| Intranasal Drug Delivery Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027 |
| German Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019 |
| German Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| German Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 |
| Italy |
| Italian Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Historic Market Analysis in Italy in US$ Million by Dosage Form: 2012-2019 |
| Italian Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market Review in Italy in US$ Million by Application: 2012-2019 |
| Italian Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| United Kingdom |
| United Kingdom Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Market in the United Kingdom: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019 |
| United Kingdom Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| United Kingdom Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 |
| Spain |
| Spanish Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027 |
| Spanish Intranasal Drug Delivery Historic Market Review by Dosage Form in US$ Million: 2012-2019 |
| Intranasal Drug Delivery Market in Spain: Percentage Share Breakdown of Sales by Dosage Form for 2012, 2020, and 2027 |
| Spanish Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Spanish Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Russia |
| Russian Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027 |
| Intranasal Drug Delivery Market in Russia by Dosage Form: A Historic Review in US$ Million for 2012-2019 |
| Russian Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Russian Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019 |
| Intranasal Drug Delivery Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 |
| Rest of Europe |
| Rest of Europe Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027 |
| Intranasal Drug Delivery Market in Rest of Europe in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019 |
| Rest of Europe Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Rest of Europe Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Intranasal Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Rest of Europe Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Asia-Pacific |
| Asia-Pacific Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Intranasal Drug Delivery Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019 |
| Asia-Pacific Intranasal Drug Delivery Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in Asia-Pacific by Dosage Form: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Intranasal Drug Delivery Historic Market Scenario in US$ Million by Dosage Form: 2012-2019 |
| Asia-Pacific Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 |
| Asia-Pacific Intranasal Drug Delivery Historic Market Review in US$ Million by Application: 2012-2019 |
| Asia-Pacific Intranasal Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Australia |
| Intranasal Drug Delivery Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027 |
| Australian Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019 |
| Australian Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| Australian Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 |
| India |
| Indian Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027 |
| Indian Intranasal Drug Delivery Historic Market Review by Dosage Form in US$ Million: 2012-2019 |
| Intranasal Drug Delivery Market in India: Percentage Share Breakdown of Sales by Dosage Form for 2012, 2020, and 2027 |
| Indian Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Indian Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| South Korea |
| Intranasal Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027 |
| South Korean Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in South Korea by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 |
| South Korean Intranasal Drug Delivery Historic Market Analysis in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019 |
| Rest of Asia-Pacific Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Rest of Asia-Pacific Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 |
| Latin America |
| Latin American Intranasal Drug Delivery Market Trends by Region/Country in US$ Million: 2020-2027 |
| Intranasal Drug Delivery Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019 |
| Latin American Intranasal Drug Delivery Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 |
| Latin American Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Historic Market Analysis in Latin America in US$ Million by Dosage Form: 2012-2019 |
| Latin American Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Latin American Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market Review in Latin America in US$ Million by Application: 2012-2019 |
| Latin American Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Argentina |
| Argentinean Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027 |
| Intranasal Drug Delivery Market in Argentina in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019 |
| Argentinean Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Argentinean Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Intranasal Drug Delivery Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Argentinean Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Brazil |
| Intranasal Drug Delivery Market in Brazil by Dosage Form: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Brazilian Intranasal Drug Delivery Historic Market Scenario in US$ Million by Dosage Form: 2012-2019 |
| Brazilian Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027 |
| Brazilian Intranasal Drug Delivery Historic Market Review in US$ Million by Application: 2012-2019 |
| Brazilian Intranasal Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Mexico |
| Intranasal Drug Delivery Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027 |
| Mexican Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019 |
| Mexican Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| Mexican Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 |
| Rest of Latin America |
| Rest of Latin America Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027 |
| Intranasal Drug Delivery Market in Rest of Latin America by Dosage Form: A Historic Review in US$ Million for 2012-2019 |
| Rest of Latin America Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Rest of Latin America Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019 |
| Intranasal Drug Delivery Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 |
| Middle East |
| The Middle East Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Intranasal Drug Delivery Market in the Middle East by Region/Country in US$ Million: 2012-2019 |
| The Middle East Intranasal Drug Delivery Market Share Breakdown by Region/Country: 2012, 2020, and 2027 |
| The Middle East Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027 |
| The Middle East Intranasal Drug Delivery Historic Market by Dosage Form in US$ Million: 2012-2019 |
| Intranasal Drug Delivery Market in the Middle East: Percentage Share Breakdown of Sales by Dosage Form for 2012,2020, and 2027 |
| The Middle East Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| The Middle East Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Iran |
| Iranian Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Market in Iran: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019 |
| Iranian Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027 |
| Iranian Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Iranian Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027 |
| Israel |
| Israeli Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027 |
| Intranasal Drug Delivery Market in Israel in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019 |
| Israeli Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Israeli Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Intranasal Drug Delivery Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Israeli Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Saudi Arabia |
| Saudi Arabian Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027 |
| Intranasal Drug Delivery Historic Market Analysis in Saudi Arabia in US$ Million by Dosage Form: 2012-2019 |
| Saudi Arabian Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Saudi Arabian Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Market Review in Saudi Arabia in US$ Million by Application: 2012-2019 |
| Saudi Arabian Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| United Arab Emirates |
| Intranasal Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027 |
| United Arab Emirates Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in United Arab Emirates by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 |
| United Arab Emirates Intranasal Drug Delivery Historic Market Analysis in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027 |
| Rest of Middle East |
| Intranasal Drug Delivery Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027 |
| Rest of Middle East Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019 |
| Rest of Middle East Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| Intranasal Drug Delivery Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| Rest of Middle East Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019 |
| Intranasal Drug Delivery Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027 |
| Africa |
| African Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027 |
| Intranasal Drug Delivery Market in Africa by Dosage Form: A Historic Review in US$ Million for 2012-2019 |
| African Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027 |
| African Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Intranasal Drug Delivery Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019 |
| Intranasal Drug Delivery Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 64 Click here to request a full table of contents and more details on this project. |
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.